Fascinatingly, PHD2 inhibition with DMOG ameliorates the skeletal muscle regenerative defects that occur with obesity with a corollary increase in HIF-1α and VEGF levels. This evidence concerns the gene HIF1A and obesity due to melanocortin 4 receptor deficiency.